Low levels of SMAD3 mRNA, which encodes a transcription factor that is activated in response to TFG-β in CD4+ T cells, was associated with the absence of GvHD, while high levels of SMAD3 were necessary but not sufficient for GvHD occurrence (94). Here, CD4 is linked to graft versus host disease.